Prevail is a life sciences investment partner that funds clinical-stage biotech and pharma projects to advance public health and improve quality of life. It provides capital to life sciences companies and connects them with potential partners seeking tomorrow’s therapies, helping both public and private companies access new medical technologies. Its offerings center on financing arrangements and strategic partnerships that move clinical-stage programs forward. Prevail differentiates itself by acting as a dedicated capital partner that bridges early-stage research with market opportunities, giving portfolio companies access to both public and private investment channels and potential collaborators. The firm’s goal is to accelerate the development of promising medical technologies and therapies to benefit patients and societies.
Company Size
1-10
Company Stage
N/A
Total Funding
$28.2M
Headquarters
Philadelphia, Pennsylvania
Founded
2015
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?